GLMD (GLMD) Stock Price & Analysis
GLMD (GLMD) fell 1.02% to USD 3.88 as of September 8, 2026 at 09:33 UTC, according to Nexqual real-time market data.
GLMD last closed at USD 3.88; the session ranged USD 3.88–4.23 on volume of 4,082 shares. Market capitalization is —, with a 52-week range of USD 3.29–13.2 (NCM). Source: Nexqual, September 8, 2026 at 09:33 UTC.
Key Statistics (as of September 8, 2026 at 09:33 UTC)
| Price | USD 3.88 |
|---|---|
| Change | ▼ 1.02% (down) |
| Previous Close | USD 3.88 |
| Open | USD 3.88 |
| Day Range | USD 3.88 – 4.23 |
| 52-Week Range | USD 3.29 – 13.2 |
| Volume | 4,082 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (GLMD)
Nexqual's technical model rates GLMD "SELL" based on 1 bullish and 5 bearish signals across 128 daily candles, as of September 8, 2026 at 09:33 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.58 (neutral) |
| vs SMA50 | Below (USD 4.4) |
| MACD | -0.14 (negative) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| GALT | Galectin Therapeutics Inc. | USD 4.61 | ▲ 2.9% |
| RDHL | Redhill Biopharma Ltd. | USD 0.72 | ▼ 2.24% |
| NCNA | NuCana plc | USD 1.4 | ▲ 0.72% |
| PRQR | ProQR Therapeutics N.V. | USD 2.07 | ▼ 3.72% |
| AFMDQ | Affimed N.V. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 09:33 UTC. This page is informational and not investment advice.